Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Jos Jonkers
Based on 58 articles published since 2009
(Why 58 articles?)
||||
Expertise Level
The expertise of Jos Jonkers ranks in the
  • Top 0.18%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 58 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Jonkers, Jos   ·   Jonkers, J
Work Locations
Details
Most likely:    Leeuwenhoek Hospital      
2019
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · ACRF Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. · Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia. · Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Medicine, University of Medicine, Parkville, VIC, 3010, Australia. · Parkville Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, VIC, 3050, Australia. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 30674894
2018
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 30465162
  • Genome Integrity Laboratory, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. · Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia. · Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, BN1 9RQ, UK. · MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford, OX1 3TH, UK. · Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK. · CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK. · Department of Medicine at St. Vincent's Hospital, Melbourne Medical School, The University of Melbourne, Fitzroy, VIC, 3065, Australia. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, 3012, Switzerland. · Genome Integrity Laboratory, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. · Pubmed 30559443
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
  • The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA. · MD Anderson Cancer Center, Houston, TX 77030, USA. · The Jackson Laboratory, Bar Harbor, ME 04609, USA. · Division of Hematology Oncology, Department of Medicine, and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. · Oncode Institute and Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · The Jackson Laboratory, Bar Harbor, ME 04609, USA. Electronic address: · Pubmed 30017478
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZC, the Netherlands. · Institute of Molecular Cancer Research, University of Zurich, Zurich CH-8057, Switzerland. · Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9723GZ, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Cell Biology and BioImaging Facility, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark; Karolinska Institute, Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Science for Life Laboratory, Stockholm 171 77, Sweden. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark. · Pathology Department, Complejo Hospt. Univ. Insular Materno Infantil, Las Palmas, Gran Canaria, Spain. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. Electronic address: · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern 3012, Switzerland. Electronic address: · Pubmed 29894693
  • Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Cancer Research, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 29774524
  • The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. · Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom. · The Breast Cancer Now Research Unit, King's College London, London, United Kingdom. · Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Biomedical Research Institute INCLIVA, Hospital Clinico Universitario Valencia, University of Valencia, Spain. · FACS Core Facility, The Institute of Cancer Research, London, United Kingdom. · Division of Cancer Studies, Guy's Hospital, King's College London, London, United Kingdom. · Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. · Systems Biology Ireland, University College Dublin, Dublin, Ireland. · Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Division of Molecular Pathology and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. · Pubmed 29610289
  • Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 29326437
  • Institute of Pathology, Hannover Medical School, Hannover, Germany. · Institute of Laboratory Animal Science, Hannover Medical School, Hannover, Germany. · Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany. · West German Study Group, Moenchengladbach, Germany. · Breast Center Niederrhein, Evangelic Bethesda Hospital, Moenchengladbach, Germany. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Pubmed 29035379
2017
  • Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · The Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Sydney, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Pubmed 28821557
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. · Division of Molecular Pathology and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · European Research Institute for the Biology of Ageing, University of Groningen University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. · The CRUK/MRC Oxford Institute, Old Road Campus Research Building, OX3 7DQ Oxford, UK. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Laenggassstrasse 122, 3012 Bern, Switzerland. · Pubmed 28714471
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 28650484
  • Division of Molecular Pathology and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Faculty of EEMCS, Delft University of Technology, Mekelweg 4, Delft 2628 CD, The Netherlands. · Pubmed 28575524
  • Institut Curie, PSL Research University, CNRS, UMR144, Paris, France. · Institut de Cancérologie de l'Ouest, Bvd Jacques Monod, Saint Herblain, France. · GenoSplice Technology, iPEPS - ICM, Hôpital Pitié Salpêtrière, Paris, France. · Division of Molecular Pathology and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institut national de la santé et de la recherché médicale, Paris, France. · Pubmed 27775073
2016
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Pubmed 27815543
  • Oncoproteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Switzerland. · Pubmed 27566577
  • Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Section of Molecular Cytology and Van Leeuwenhoek Centre for Advanced Microscopy, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, the Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 27524621
  • Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Vascular Biology and Tumor Angiogenesis, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany. · Department of Medical Oncology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 27411687
  • Affiliations of authors: Division of Molecular Pathology and Cancer Genomics Centre Netherlands (PtB, PK, EvdB, UB, MdM, EL, LM, JdR, JW, JJ), Division of Molecular Carcinogenesis (IM), Department of Epidemiology and Biostatistics (KJ), and Family Cancer Clinic and Department of Pathology (FH), The Netherlands Cancer Institute, Amsterdam, the Netherlands · Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain (CM, ME) · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK (HG, NT) · Laboratory of Preclinical Investigation, Translational Research Department, Curie Institute, Paris, France (EM) · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (WK, MvR, KD, EC) · Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain (ME) · Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain (ME). · Pubmed 27381626
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Experimental Animal Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Pubmed 27340177
  • Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Department of Obstetrics and Gynecology and Medicine, University of Washington, Seattle, Washington. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil. Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom. · Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. · University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom. · VIB Vesalius Research Center, University of Leuven, Leuven, Belgium. · QIMR Berghofer Medical Research Institute, Herston, Australia. · Departments of Cancer Epidemiology and Oncology, Lund University, Lund, Sweden. · Human Genetics Group and Human Genotyping Unit Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. · Royal Marsden NHS Foundation Trust, London, United Kingdom. · University of California San Francisco, Cancer Risk Program, San Francisco, California. · Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California. · Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Department of Pediatrics, Children's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Risk Assessment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Pubmed 27197267
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
2015
  • Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Mouse Clinic for Cancer and Aging (MCCA) Transgenic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Department of Molecular Cell Biology, Leiden University Medical Center, Einsteinweg 20, 2333 ZC Leiden, The Netherlands; · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Mouse Clinic for Cancer and Aging (MCCA) Transgenic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Pubmed 26100884
  • Divisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands. · Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Pubmed 25822788
  • Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK. · Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. · Department of Obstetrics & Gynecology, Faculty of Medicine, Juntendo University, Bunkyoku, Tokyo, Japan. · Division of Molecular Pathology and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Pubmed 25531315
  • Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Pubmed 25511378
2014
  • Division of Molecular Pathology and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23955079
  • Institute for Molecular Medicine Finland (FIMM), University of Helsinki, PO Box 20, Helsinki 00014, Finland. · Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Unit of Systems Toxicology, Finnish Institute of Occupational Health (FIOH), Helsinki, Finland. · Pubmed 25522274
  • Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Department of Biochemistry & Molecular Biology, Braman Family Breast Cancer Institute at Sylvester, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. · Department of Medicine, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Department of Public Health Sciences, Division of Biostatistics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Department of Biochemistry & Molecular Biology, Braman Family Breast Cancer Institute at Sylvester, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. · Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 25417103
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands. · Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Toxicogenetics, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands. · AstraZeneca, iMed Oncology, Macclesfield, Cheshire, United Kingdom. · Department of Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. Cancer Genomics Center Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands. Department of Radiation Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Toxicogenetics, Leiden University Medical Center, Leiden, the Netherlands. Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Department of Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Pubmed 24963051
2012
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22684454
2015
  • aDivision of Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands bDepartment of Anesthesiology, Academic Medical Center, Amsterdam, the Netherlands cDivision of Molecular Pathology and Cancer Genomics Center, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 25734987
2014
  • Authors' Affiliation: Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 24270682
2013
  • Division of Molecular Pathology, Cancer Genomics Centre Netherlands and Cancer Systems Biology Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 23478237
  • 1Division of Molecular Pathology and Cancer Genomics Centre and 2Department of Pathology, The Netherlands Cancer Institute Amsterdam, The Netherlands; and 3TaconicArtemis GmbH, Cologne, Germany. · Pubmed 23867111
  • Division of Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23151903
2012
  • Division of Molecular Biology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 21922196
  • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22396490
2011
  • Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21282721
2010
  • Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21118481
Probable:    Miscellaneous institutions in Amsterdam      
2018
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
2017
  • Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. · Division of Molecular Pathology and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands. · University of Amsterdam, Amsterdam 1012 WX, the Netherlands. · Department of Medical Oncology, Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern 3012, Switzerland. · Pubmed 29035360
2014
  • Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. Sheba Cancer Research Center, Sheba Medical Center, Ramat-Gan 52621, Israel. Sackler school of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. · Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. · Sheba Cancer Research Center, Sheba Medical Center, Ramat-Gan 52621, Israel. · Department of Human Science, Georgetown University Medical Center, Washington DC 20057, USA. · Division of Molecular Pathology and Cancer Genomic Center, The Netherland Cancer Institute, Amsterdam 1066, The Netherlands. · Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, NW Washington DC 20057, USA. · Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. Sackler school of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. · Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. Sheba Cancer Research Center, Sheba Medical Center, Ramat-Gan 52621, Israel. Department of Human Science, Georgetown University Medical Center, Washington DC 20057, USA. Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, NW Washington DC 20057, USA. · Pubmed 25460500
2015
  • Biomolecular Imaging Mass Spectrometry, FOM Institute AMOLF , Science Park 104, 1098 XG Amsterdam, The Netherlands. · Pubmed 25553735
Probable:    Universiteit Utrecht      
2015
  • Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam. · Netherlands Translational Research Center B.V., Oss. · Division of Molecular Pathology and Cancer Genomics Centre. · Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam. · Department of Medical Oncology. · Department of Medical Oncology Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands. · Division of Molecular Pathology and Cancer Genomics Centre Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands. · Netherlands Translational Research Center B.V., Oss · Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands. · Pubmed 26153498
2013
  • Department of Pathology, Cancer Center, and Division of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 23733751
2011
  • Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 21747168
  • Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21282721
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 58 total) written by Jos Jonkers about Breast Neoplasms:

  • Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer. 2019
  • Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. 2018
  • The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity. 2018
  • A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. 2018
  • Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547. 2018
  • The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations. 2018
  • Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality. 2018
  • αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer. 2018
  • RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. 2018
  • E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer. 2018
Show List of Full Article Records
Google Searches

Learn more about Jos Jonkers using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Leeuwenhoek Hospital
Miscellaneous institutions in Amsterdam
Universiteit Utrecht
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Leeuwenhoek Hospital
2019
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · ACRF Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. · Department of Medical Biology, University of Melbourne, Parkville, VIC, 3010, Australia. · Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Medicine, University of Medicine, Parkville, VIC, 3010, Australia. · Parkville Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, VIC, 3050, Australia. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Oncode Institute, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 30674894
2018
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 30465162
  • Genome Integrity Laboratory, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. · Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · St. Vincent's Institute of Medical Research, Fitzroy, VIC, 3065, Australia. · Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, BN1 9RQ, UK. · MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford, OX1 3TH, UK. · Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK. · CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK. · Department of Medicine at St. Vincent's Hospital, Melbourne Medical School, The University of Melbourne, Fitzroy, VIC, 3065, Australia. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, 3012, Switzerland. · Genome Integrity Laboratory, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. · Pubmed 30559443
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Genome Stability Laboratory, CHU de Québec Research Center, Québec City, QC, Canada. · Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada. · CHU de Quebec - Université Laval Research Center, Genomics Center CHUL, Québec City, QC, Canada. · Department of Medical Oncology, University Hospital of Parma, Parma, Italy. · Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Oncology Data Science (OdysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. · Department of Radiology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Dalhousie University, Halifax, NS, Canada. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · AstraZeneca, Waltham, MA, USA. · Breast Cancer Programme, Cancer Research UK (CRUK) Cambridge Cancer Centre, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · XenTech, Evry, France. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Oncology Innovative Medicines and Early Clinical Development Biotech Unit, AstraZeneca, Cambridge, UK. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · High Risk and Familial Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Pubmed 30377213
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
  • The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA. · MD Anderson Cancer Center, Houston, TX 77030, USA. · The Jackson Laboratory, Bar Harbor, ME 04609, USA. · Division of Hematology Oncology, Department of Medicine, and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. · Oncode Institute and Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · The Jackson Laboratory, Bar Harbor, ME 04609, USA. Electronic address: · Pubmed 30017478
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZC, the Netherlands. · Institute of Molecular Cancer Research, University of Zurich, Zurich CH-8057, Switzerland. · Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9723GZ, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. · Division of Cell Biology and BioImaging Facility, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands. · CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark; Karolinska Institute, Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Science for Life Laboratory, Stockholm 171 77, Sweden. · Danish Cancer Society Research Center, Copenhagen 2100, Denmark. · Pathology Department, Complejo Hospt. Univ. Insular Materno Infantil, Las Palmas, Gran Canaria, Spain. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, Amsterdam 1066CX, the Netherlands. Electronic address: · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, the Netherlands; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern 3012, Switzerland. Electronic address: · Pubmed 29894693
  • Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Cancer Research, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 29774524
  • The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. · Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom. · The Breast Cancer Now Research Unit, King's College London, London, United Kingdom. · Mouse Clinic for Cancer and Aging (MCCA) Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Biomedical Research Institute INCLIVA, Hospital Clinico Universitario Valencia, University of Valencia, Spain. · FACS Core Facility, The Institute of Cancer Research, London, United Kingdom. · Division of Cancer Studies, Guy's Hospital, King's College London, London, United Kingdom. · Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. · Systems Biology Ireland, University College Dublin, Dublin, Ireland. · Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Division of Molecular Pathology and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. · Pubmed 29610289
  • Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 29326437
  • Institute of Pathology, Hannover Medical School, Hannover, Germany. · Institute of Laboratory Animal Science, Hannover Medical School, Hannover, Germany. · Department of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany. · West German Study Group, Moenchengladbach, Germany. · Breast Center Niederrhein, Evangelic Bethesda Hospital, Moenchengladbach, Germany. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Pubmed 29035379
2017
  • Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · The Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Sydney, Australia. · St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Pubmed 28821557
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. · Division of Molecular Pathology and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · European Research Institute for the Biology of Ageing, University of Groningen University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. · The CRUK/MRC Oxford Institute, Old Road Campus Research Building, OX3 7DQ Oxford, UK. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Laenggassstrasse 122, 3012 Bern, Switzerland. · Pubmed 28714471
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Pubmed 28650484
  • Division of Molecular Pathology and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Division of Molecular Carcinogenesis and Cancer Genomics Netherlands, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Faculty of EEMCS, Delft University of Technology, Mekelweg 4, Delft 2628 CD, The Netherlands. · Pubmed 28575524
  • Institut Curie, PSL Research University, CNRS, UMR144, Paris, France. · Institut de Cancérologie de l'Ouest, Bvd Jacques Monod, Saint Herblain, France. · GenoSplice Technology, iPEPS - ICM, Hôpital Pitié Salpêtrière, Paris, France. · Division of Molecular Pathology and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institut national de la santé et de la recherché médicale, Paris, France. · Pubmed 27775073
2016
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Pubmed 27815543
  • Oncoproteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Switzerland. · Pubmed 27566577
  • Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Section of Molecular Cytology and Van Leeuwenhoek Centre for Advanced Microscopy, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, the Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, 3584 CG Utrecht, the Netherlands. Electronic address: · Pubmed 27524621
  • Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Vascular Biology and Tumor Angiogenesis, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany. · Department of Medical Oncology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 27411687
  • Affiliations of authors: Division of Molecular Pathology and Cancer Genomics Centre Netherlands (PtB, PK, EvdB, UB, MdM, EL, LM, JdR, JW, JJ), Division of Molecular Carcinogenesis (IM), Department of Epidemiology and Biostatistics (KJ), and Family Cancer Clinic and Department of Pathology (FH), The Netherlands Cancer Institute, Amsterdam, the Netherlands · Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain (CM, ME) · The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK (HG, NT) · Laboratory of Preclinical Investigation, Translational Research Department, Curie Institute, Paris, France (EM) · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands (WK, MvR, KD, EC) · Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain (ME) · Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain (ME). · Pubmed 27381626
  • Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Experimental Animal Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; Cancer Genomics Netherlands, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Pubmed 27340177
  • Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Department of Obstetrics and Gynecology and Medicine, University of Washington, Seattle, Washington. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil. Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom. · Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. · University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom. · VIB Vesalius Research Center, University of Leuven, Leuven, Belgium. · QIMR Berghofer Medical Research Institute, Herston, Australia. · Departments of Cancer Epidemiology and Oncology, Lund University, Lund, Sweden. · Human Genetics Group and Human Genotyping Unit Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. · Royal Marsden NHS Foundation Trust, London, United Kingdom. · University of California San Francisco, Cancer Risk Program, San Francisco, California. · Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California. · Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Department of Pediatrics, Children's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Risk Assessment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Pubmed 27197267
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
2015
  • Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Mouse Clinic for Cancer and Aging (MCCA) Transgenic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Department of Molecular Cell Biology, Leiden University Medical Center, Einsteinweg 20, 2333 ZC Leiden, The Netherlands; · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Mouse Clinic for Cancer and Aging (MCCA) Transgenic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; · Pubmed 26100884
  • Divisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands. · Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Pubmed 25822788
  • Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK. · Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. · Department of Obstetrics & Gynecology, Faculty of Medicine, Juntendo University, Bunkyoku, Tokyo, Japan. · Division of Molecular Pathology and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Pubmed 25531315
  • Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. · Pubmed 25511378
2014
  • Division of Molecular Pathology and Cancer Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23955079
  • Institute for Molecular Medicine Finland (FIMM), University of Helsinki, PO Box 20, Helsinki 00014, Finland. · Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Unit of Systems Toxicology, Finnish Institute of Occupational Health (FIOH), Helsinki, Finland. · Pubmed 25522274
  • Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Department of Biochemistry & Molecular Biology, Braman Family Breast Cancer Institute at Sylvester, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. · Department of Medicine, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Department of Public Health Sciences, Division of Biostatistics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. · Department of Biochemistry & Molecular Biology, Braman Family Breast Cancer Institute at Sylvester, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA; Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. · Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 25417103
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands. · Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Toxicogenetics, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands. · AstraZeneca, iMed Oncology, Macclesfield, Cheshire, United Kingdom. · Department of Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. Cancer Genomics Center Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands. Department of Radiation Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Toxicogenetics, Leiden University Medical Center, Leiden, the Netherlands. Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Department of Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Pubmed 24963051
2012
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22684454
2015
  • aDivision of Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands bDepartment of Anesthesiology, Academic Medical Center, Amsterdam, the Netherlands cDivision of Molecular Pathology and Cancer Genomics Center, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 25734987
2014
  • Authors' Affiliation: Division of Molecular Pathology and Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 24270682
2013
  • Division of Molecular Pathology, Cancer Genomics Centre Netherlands and Cancer Systems Biology Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 23478237
  • 1Division of Molecular Pathology and Cancer Genomics Centre and 2Department of Pathology, The Netherlands Cancer Institute Amsterdam, The Netherlands; and 3TaconicArtemis GmbH, Cologne, Germany. · Pubmed 23867111
  • Division of Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23151903
2012
  • Division of Molecular Biology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Pubmed 21922196
  • Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 22396490
2011
  • Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21282721
2010
  • Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21118481
Miscellaneous institutions in Amsterdam
2018
  • Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. · Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Amsterdam, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, the Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 30115694
2017
  • Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. · Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. · Division of Molecular Pathology and Cancer Genomics Netherlands, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands. · Mouse Clinic for Cancer and Aging (MCCA), Preclinical Intervention Unit, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands. · University of Amsterdam, Amsterdam 1012 WX, the Netherlands. · Department of Medical Oncology, Medical Gynecologic Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. · Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern 3012, Switzerland. · Pubmed 29035360
2014
  • Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. Sheba Cancer Research Center, Sheba Medical Center, Ramat-Gan 52621, Israel. Sackler school of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. · Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. · Sheba Cancer Research Center, Sheba Medical Center, Ramat-Gan 52621, Israel. · Department of Human Science, Georgetown University Medical Center, Washington DC 20057, USA. · Division of Molecular Pathology and Cancer Genomic Center, The Netherland Cancer Institute, Amsterdam 1066, The Netherlands. · Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, NW Washington DC 20057, USA. · Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. Sackler school of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. · Laboratory of Genomic Applications, Department of Surgical Oncology, Sheba Medical Center, Ramat-Gan 52621, Israel. Sheba Cancer Research Center, Sheba Medical Center, Ramat-Gan 52621, Israel. Department of Human Science, Georgetown University Medical Center, Washington DC 20057, USA. Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, NW Washington DC 20057, USA. · Pubmed 25460500
2015
  • Biomolecular Imaging Mass Spectrometry, FOM Institute AMOLF , Science Park 104, 1098 XG Amsterdam, The Netherlands. · Pubmed 25553735
Unspecified
2018
  • Experimental Therapeutics Group. · High Risk and Familial Cancer, Vall d'Hebron Institute of Oncology, Barcelona. · Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona. · Oncogenetics Group. · Growth Factors Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge. · AstraZeneca, Gatehouse Park, Waltham, USA. · DNA Damage Response Biology Area, Oncology iMed, AstraZeneca, Cancer Research UK Cambridge Institute, Cambridge, UK. · Division of Molecular Pathology and Cancer Genomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Genomics Group. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona. · Department of Radiology. · Breast Surgical Unit, Breast Cancer Center, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona. · Gynecological Malignancies Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Human Oncology and Pathogenesis Program (HOPP). · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona. · Ramón y Cajal University Hospital, Madrid. · Vall d'Hebron Institute of Oncology, Barcelona. · Department of Biochemistry and Molecular Biology, Building M, Campus UAB, Bellaterra (Cerdanyola del Vallès). · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona. · CIBERONC, Barcelona. · Clinical and Molecular Genetics Area, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · DNA Damage Response Biology Area, Oncology Innovative Medicine and Early Development Biotech Unit, AstraZeneca, Cambridge, UK. · Pubmed 29635390
2016
  • Center for Innovative Medicine (CIMED), Department of Biosciences and Nutrition, Karolinska Institutet, Novum, 141 83 Huddinge, Sweden. · Adult Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. · Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Novum, 141 83 Huddinge, Sweden. · Experimental Histopathology, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. · Bioinformatics and Biostatistics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. · Advanced Sequencing Facility, The Francis Crick Institute, Mill Hill Laboratory, The Ridgeway, London NW7 1AA, UK. · Division of Molecular Pathology and Cancer, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Tumour-Stroma Interactions in Cancer Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. · Faculty of Life Sciences &Medicine, King's College London, Guy's Campus, London SE1 1UL, UK. · Pubmed 27798604
Universiteit Utrecht
2015
  • Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam. · Netherlands Translational Research Center B.V., Oss. · Division of Molecular Pathology and Cancer Genomics Centre. · Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam. · Department of Medical Oncology. · Department of Medical Oncology Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands. · Division of Molecular Pathology and Cancer Genomics Centre Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands. · Netherlands Translational Research Center B.V., Oss · Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam Department of Cancer Genomics Netherlands, UMC Utrecht, Utrecht, The Netherlands. · Pubmed 26153498
2013
  • Department of Pathology, Cancer Center, and Division of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 23733751
2011
  • Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 21747168
  • Division of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 21282721
5 Other Locations Show
Yearly article counts 1116108865210
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.